ZA200002207B - Substituted pyridine or piperidine compounds, a process for their preparation and pharmaceutical compositions containing them. - Google Patents

Substituted pyridine or piperidine compounds, a process for their preparation and pharmaceutical compositions containing them.

Info

Publication number
ZA200002207B
ZA200002207B ZA200002207A ZA200002207A ZA200002207B ZA 200002207 B ZA200002207 B ZA 200002207B ZA 200002207 A ZA200002207 A ZA 200002207A ZA 200002207 A ZA200002207 A ZA 200002207A ZA 200002207 B ZA200002207 B ZA 200002207B
Authority
ZA
South Africa
Prior art keywords
group
alkoxy
pyridine
piperidine
preparation
Prior art date
Application number
ZA200002207A
Other languages
English (en)
Inventor
Otto Meth-Cohn
Chu-Yi Yu
Pierre Lestage
Marie-Cecile Lebrun
Daniel-Henri Caignard
Renard Pierre
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of ZA200002207B publication Critical patent/ZA200002207B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ZA200002207A 1999-05-05 2000-05-05 Substituted pyridine or piperidine compounds, a process for their preparation and pharmaceutical compositions containing them. ZA200002207B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9905690A FR2793245B1 (fr) 1999-05-05 1999-05-05 Nouveaux composes pyridiniques ou piperidiniques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ZA200002207B true ZA200002207B (en) 2000-11-14

Family

ID=9545222

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200002207A ZA200002207B (en) 1999-05-05 2000-05-05 Substituted pyridine or piperidine compounds, a process for their preparation and pharmaceutical compositions containing them.

Country Status (22)

Country Link
US (6) US6323220B1 (xx)
EP (1) EP1050531B1 (xx)
JP (2) JP3533361B2 (xx)
KR (1) KR100472519B1 (xx)
CN (1) CN100371326C (xx)
AT (1) ATE282595T1 (xx)
AU (1) AU764388B2 (xx)
BR (1) BR0002287A (xx)
CA (1) CA2308867C (xx)
DE (1) DE60015844T2 (xx)
DK (1) DK1050531T3 (xx)
EA (1) EA003053B1 (xx)
ES (1) ES2233302T3 (xx)
FR (1) FR2793245B1 (xx)
HU (1) HUP0001789A3 (xx)
MX (1) MXPA00004343A (xx)
NO (1) NO317095B1 (xx)
NZ (1) NZ504338A (xx)
PL (1) PL197661B1 (xx)
PT (1) PT1050531E (xx)
SI (1) SI1050531T1 (xx)
ZA (1) ZA200002207B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7687513B1 (en) 2004-10-21 2010-03-30 University Of Notre Dame Du Lac Aminopyridinium ionic liquids
US7812098B2 (en) * 2006-03-31 2010-10-12 Depuy Products, Inc. Bearing material of medical implant having reduced wear rate and method for reducing wear rate
FR2905009A1 (fr) * 2006-08-18 2008-02-22 Servier Lab Methode de criblage de composes aux proprietes anti-amyloide
EP2217236A1 (en) * 2007-11-02 2010-08-18 Yaupon Therapeutics, Inc. Use of lobeline epimers in the treatment of central nervous system diseases, pathologies, and drug abuse
WO2009061906A2 (en) * 2007-11-06 2009-05-14 Mayo Foundation For Medical Education And Research Treating protein misfolding diseases
EP2186419A1 (en) * 2008-11-13 2010-05-19 Tchibo GmbH NMP-containing extract, a method of its production and uses thereof
WO2010087313A1 (ja) * 2009-01-29 2010-08-05 株式会社林原生物化学研究所 神経突起伸展促進剤
JPWO2010087315A1 (ja) * 2009-01-29 2012-08-02 株式会社林原生物化学研究所 抗アルツハイマー病剤
EP2397139B1 (en) * 2009-01-29 2014-09-17 Hayashibara Co., Ltd. Anti-neurodegenerative disease agent
EP3982949A4 (en) * 2019-06-14 2023-10-11 Disarm Therapeutics, Inc. MRSA1 INHIBITORS

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931155A (en) * 1973-04-25 1976-01-06 Richardson-Merrell Inc. Process for preparing 2-azacycloalkylmethyl ketones
US4082806A (en) 1975-12-18 1978-04-04 Wright State University Preparation of tetraketones
JPS5328177A (en) * 1976-08-25 1978-03-16 Teijin Ltd Optical active piperidine derivatives and their preparation
DE58902111D1 (de) * 1988-03-16 1992-10-01 Ciba Geigy Ag Thioverbindungen.
ATE103910T1 (de) * 1988-06-14 1994-04-15 Searle & Co 1,2-diarylethylamine zur behandlung neurotoxischer verletzungen.
JP2522690B2 (ja) 1988-06-16 1996-08-07 富士写真フイルム株式会社 ハロゲン化銀カラ―写真感光材料
US5414005A (en) * 1993-10-28 1995-05-09 Dynagen, Inc. Methods and articles of manufacture for the treatment of nicotine withdrawal and as an aid in smoking cessation
GB9304919D0 (en) * 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
FR2756826B1 (fr) * 1996-12-05 1999-01-08 Adir Nouveaux derives tetrahydropyridiniques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US5830904A (en) * 1997-02-05 1998-11-03 University Of Kentucky Research Foundation Lobeline compounds as a treatment for psychostimulant abuse and withdrawal, and for eating disorders
US6087376A (en) * 1997-02-05 2000-07-11 University Of Kentucky Research Foundation Use of lobeline compounds in the treatment of central nervous system diseases and pathologies
EP1014981A1 (en) * 1997-02-07 2000-07-05 Synapse Pharmaceuticals International, Inc. Pharmaceutical composition for treatment of synaptic dysfunction comprising an oxime
JPH10287634A (ja) * 1997-04-11 1998-10-27 Otsuka Pharmaceut Co Ltd ベンゼン誘導体
TW544448B (en) * 1997-07-11 2003-08-01 Novartis Ag Pyridine derivatives
ES2182203T3 (es) * 1997-10-31 2003-03-01 Hoffmann La Roche Derivados de d-prolina.
US6015824A (en) * 1998-02-10 2000-01-18 Hoffmann-La Roche Ag Pyrrolidine and piperidine derivatives and treatment of neurodegenerative disorders

Also Published As

Publication number Publication date
PL339994A1 (en) 2000-11-06
EA200000389A2 (ru) 2000-12-25
ES2233302T3 (es) 2005-06-16
EA200000389A3 (ru) 2001-02-26
NO20002351L (no) 2000-11-06
EA003053B1 (ru) 2002-12-26
CN100371326C (zh) 2008-02-27
HU0001789D0 (en) 2000-07-28
CN1277192A (zh) 2000-12-20
CA2308867C (fr) 2006-03-14
JP2000355579A (ja) 2000-12-26
US6734196B2 (en) 2004-05-11
MXPA00004343A (es) 2002-03-08
FR2793245B1 (fr) 2002-10-11
SI1050531T1 (en) 2005-04-30
FR2793245A1 (fr) 2000-11-10
US20050004168A1 (en) 2005-01-06
HUP0001789A2 (en) 2001-03-28
PL197661B1 (pl) 2008-04-30
DK1050531T3 (da) 2005-03-21
HUP0001789A3 (en) 2004-04-28
DE60015844T2 (de) 2005-10-27
EP1050531B1 (fr) 2004-11-17
US20020035123A1 (en) 2002-03-21
CA2308867A1 (fr) 2000-11-05
BR0002287A (pt) 2001-01-02
EP1050531A1 (fr) 2000-11-08
KR100472519B1 (ko) 2005-03-07
US20030181484A1 (en) 2003-09-25
US6638946B2 (en) 2003-10-28
KR20010020808A (ko) 2001-03-15
AU3255200A (en) 2000-11-09
NO317095B1 (no) 2004-08-09
US6511992B2 (en) 2003-01-28
AU764388B2 (en) 2003-08-14
JP2002179652A (ja) 2002-06-26
ATE282595T1 (de) 2004-12-15
US20020040036A1 (en) 2002-04-04
US6323220B1 (en) 2001-11-27
JP3533361B2 (ja) 2004-05-31
PT1050531E (pt) 2005-03-31
US20030139408A1 (en) 2003-07-24
NZ504338A (en) 2001-06-29
NO20002351D0 (no) 2000-05-04
DE60015844D1 (de) 2004-12-23

Similar Documents

Publication Publication Date Title
CA2450922A1 (en) Piperidines for use as orexin receptor antagonists
DK131893A (da) 2-(Substitueret methyl)-4-(substitueret ethoxy)-5-(lavere alkyl)-pyridinforbindelser, farmaceutisk præparat, som indeholder sådanne samt anvendelse af en sådan forbindelse til fremstilling af et farmaceutisk præparat
RU98119523A (ru) Соединения пиперазина и пиперидина
KR870001196A (ko) 피리딘 화합물과 그의 제법 및 그를 함유하는 약학조성물
MXPA03010584A (es) Derivados de tiazol u oxazol que son utiles en el tratamiento de enfermedades cardiovasculares y relacionadas.
RU98117621A (ru) Новые производные пиперазина и пиперидина, способ их получения, фармкомпозиция на их основе, способ лечения, промежуточный продукт
FR2844270B1 (fr) Derives de la quinolyl propyl piperidine, leur procede et intermediaires de preparation et les compositions qui les contiennent
ZA200005668B (en) Benzothiopene, benzofuran and indole compounds, a process for their preparation and pharmaceutical compositions containing them.
EP0040639A4 (en) ISOXAZOLE DERIVATIVES.
AU7127794A (en) 3,5-dioxo-(2h,4h)-1,2,4-triazine derivatives as 5ht1a ligands
RU2002107318A (ru) Новые фенилпиперазины
ZA200002207B (en) Substituted pyridine or piperidine compounds, a process for their preparation and pharmaceutical compositions containing them.
DK163288A (da) 2-(4-(4-(4-((2-(2,4-difluorphenyl)-2-(1h-azolylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-1-piperazinyl)triazoloner
HUT36113A (en) Process for preparing dihydro-pyridibes with anti-ischaemic activity and blood pressure decreasing effect and pharmaceutical compositions containing such compounds
KR930004262A (ko) 메타노안트라센 화합물
KR920016422A (ko) N-페닐카바메이트 화합물, 이의 제조방법 및 유해한 유기체를 방제하기 위한 살균 조성물
IE791851L (en) 4-(naphthylmethyl) piperidine derivatives
GB1319026A (en) Imidazole derivatives
KR970704692A (ko) 류코트리엔 생합성의 억제제로서의 이미녹시카복실레이트 및 이의 유도체(Iminoxycarboxylates and derivatives as inhibitors of leukotriene biosynthesis)
AU4440397A (en) New heterocyclic aminomethyl compounds, process for preparing them and pharmaceutical compositions containing them
ATE75737T1 (de) Indenothiazolderivate und verfahren zu ihrer herstellung.
CA1246583A (en) 4-ISOXAZOLYL)-THIAZOLE-2-OXAMIC ACIDS AND THEIR DERIVATIVES
KR930004234A (ko) 메타노안트라센 화합물
ES8105981A1 (es) Procedimiento para la preparacion de derivados de 4-(nafta- leniloxi)piperidina
BR0013375A (pt) Composições farmacêuticas contendo derivados tiazolidinodiona e processo para sua preparação